Finance

Beta
Ask
Lists
524314:BOM
Gujarat Terce Laboratories Ltd
₹34.12
-6.08%
(-2.21) 1D
Jun 19, 3:45:13 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524314...
Open
₹35.11
High
₹35.11
Low
₹34.00
Mkt. cap
265.84M
Avg. vol.
3.91K
Volume
7.39K
P/E ratio
11.68
52-wk high
₹59.78
52-wk low
₹29.00
EPS
₹2.92
No. of employees
244
Open
₹35.11
High
₹35.11
Low
₹34.00
Mkt. cap
265.84M
Avg. vol.
3.91K
Volume
7.39K
P/E ratio
11.68
52-wk high
₹59.78
52-wk low
₹29.00
EPS
₹2.92
No. of employees
244
News stories
From sources across the web
About Gujarat Terce Laboratories Ltd
CEO-
Employees244
Founded1985
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Dec 2024
Mar 2025
Dec 2025
Mar 2026
Revenue
126.81M
123.24M
122.94M
113.99M
Cost of goods sold
44.82M
57.60M
45.04M
38.93M
Cost of revenue
44.82M
57.60M
45.04M
38.93M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.77M
74.78M
40.33M
41.19M
Operating expense
72.04M
56.14M
67.48M
68.99M
Total operating expenses
116.86M
113.74M
112.52M
107.92M
Operating income
9.95M
9.50M
10.41M
6.07M
Other non operating income
672.00K
-2.34M
1.27M
766.00K
EBT including unusual items
9.78M
9.68M
11.28M
2.05M
EBT excluding unusual items
9.78M
9.57M
11.28M
6.59M
Income tax expense
-303.00K
43.60M
3.67M
1.04M
Effective tax rate
-3.10%
450.20%
32.53%
50.66%
Other operating expenses
31.31M
-19.66M
26.19M
26.46M
Net income
10.08M
-33.91M
7.61M
1.01M
Net profit margin
7.95%
-27.52%
6.19%
0.89%
Earnings per share
-
-
-
-
Interest and investment income
-
2.56M
-
-
Interest expense
-845.00K
-148.00K
-399.00K
-253.00K
Net interest expenses
-845.00K
2.41M
-399.00K
-253.00K
Depreciation and amortization charges
953.00K
1.02M
961.00K
1.34M
EBITDA
10.87M
10.46M
11.37M
7.13M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more